Scimplify’s $25M Raise Tests Non-Chinese Tungsten Processing Claims

Scimplify has raised $25 million to move processing and purification capacity into the US. The company has not yet disclosed a single plant location, volume or price for its tungsten work. That gap raises a question about critical materials processing more broadly: is “non-Chinese supply” a verified fact, or a label applied before the evidence arrives?

The round, reported by TechCrunch on 14 October 2026, was led by Hitachi Ventures, with Henkel and Teknor Apex joining as strategic investors. The US had zero tungsten mine production in 2025. It also sources more than 95% of its rare earths from abroad, according to the Department of Energy (DOE).

The raise is a test of whether a lab-to-factory model built on manufacturing partners can fix the layer that sits after mining. If you hold critical minerals exposure, that layer is where much of the pricing power now sits.

This analysis separates what the raise proves from what it leaves open, so you can judge how much weight to give the model.

Why does processing, not mining, hold the supply chain back?

A country can hold ore, or import plenty of it, and still be exposed. The International Energy Agency (IEA) made this point on 11 September 2026: whoever controls conversion into oxides, metals, alloys or magnets holds the leverage.

What processing actually is

Processing turns raw ore or recovered scrap into material a manufacturer can use. The main steps are separation, purification, impurity removal and conversion into oxides, metals, alloys or magnets. Purity is the level of unwanted elements left in the final product, and buyers set strict limits on it.

The path from mine to refinery involves several handoffs, and each one, from concentrate production to oxide conversion, is a point where leverage can shift to whoever controls the next step.

Spent industrial catalysts are a good example. They contain tungsten mixed with other metals. A processor dissolves the material, strips out contaminants and converts what remains into a high-purity tungsten compound that meets a buyer’s specification.

Five reasons the bottleneck persists

1. Cost and scale: Processing plants are capital-intensive and often uneconomic without steady throughput and long-term offtake (contracts to buy future output).
2. Permitting: Separation creates hard-to-manage waste streams that need permits for water, emissions and hazardous reagents.
3. Technical expertise: Purity depends on tight process control and customer qualification, the testing a buyer runs before approving a supplier.
4. Feedstock and demand coordination: The Center for Strategic and International Studies (CSIS) argued on 25 March 2026 that permits alone are not enough without buyers and scale.
5. Installed Chinese scale: Lower unit costs, experienced labour and integrated customers make new Western plants harder to finance.

The US Geological Survey (USGS) data shows how deep that dependence runs.

DOE, 14 May 2026 The US receives more than 95% of its rare-earth supply from foreign sources, and at least 14 critical minerals are sourced exclusively from abroad.

Prices followed the controls. In 2025, 65% tungsten concentrate rose from $266 to $551 per metric ton unit, and ammonium paratungstate (APT), a refined intermediate, rose from $331 to $675.

Washington has responded with money aimed squarely at the processing layer. The DOE committed $45.7 million to 19 projects in May, opened a funding opportunity of up to $69 million in April and selected nine industrial-feedstock recovery projects worth $162 million in August. The price spike and the licensing regime tell you that exposure sits in processing, so a thesis built only on mine supply misses where the risk actually sits.

How Scimplify’s lab-to-factory model works, and where it could break

That funding push explains why an asset-light processor attracts strategic capital. The appeal is easy to see.

The model and the money

Scimplify develops each process in its labs, refines the chemistry, then hands it to engineers for scale-up at partner sites. The company reports more than 500 manufacturing partners and about 60 scientists across three labs. Its Scinode AI platform predicts synthesis routes, simulates factory production and matches projects to suitable equipment, with production results fed back to improve later runs.

The $25 million round was all equity. A person familiar with the deal told TechCrunch the post-money valuation was about $250 million, up from about $150 million after the March 2025 Series B; Scimplify did not confirm it. Total equity raised is now about $80 million.

About $7.5 million is earmarked initially for US expansion, though management said that could change. The Economic Times reported roughly $2 million for Scinode development, and the company plans to extend its network into the US and Japan.

Radhika Ananth, India Managing Director, Hitachi Ventures Demand for specialty chemicals has outpaced existing models, and Scimplify is building a platform to close the gap between India’s underused capacity and the quality systems global customers require.

Co-founder Sachin Santhosh framed the pitch around technical expertise, dependable supply and the ability to make complex materials at scale.

The pressure points

The case for partners is speed and lower capital. The case for owned plants is control. Comparables show both can work under the right conditions.

Then comes origin. An Indian contractor and a US customer do not, by themselves, make a supply chain non-Chinese. A sceptic would ask:

• Where was the feedstock mined or collected?
• Were any intermediates or reagents imported from China?
• Which plant performed the decisive purification step?
• Who owns the process data and quality system?
• Could the network keep running if China restricted reagents or equipment?

A network may reach capacity faster and with less capital, but you should read it as a bet on quality enforcement and upstream traceability. The public record does not yet show either.

What the tungsten project proves, and what it leaves out

Those open questions make the tungsten project the most important piece of evidence Scimplify has offered. It deserves credit.

The company developed a commercial-scale process that recovers high-purity tungsten from industrial scrap and spent catalysts. The customer is an unnamed US-headquartered manufacturer serving industrial and defence markets that wanted non-Chinese supply. The process reached commercial production and earned a repeat order covering one year of supply.

That is real commercial validation. It is also thinly documented.

The contrast with a binding contract is sharp. Almonty Industries’ expanded offtake with Global Tungsten & Powders (GTP) shows what lenders look for:

• Almonty and GTP: a reported 4.41 million metric ton units over 21 years, take-or-pay terms, indexed pricing and a reported $3 million upfront payment.
• Scimplify: one year of repeat supply, with no disclosed volume, price or term.

Almonty also acquired development rights at Gentung-Browns Lake in Montana, reported on 16 February 2026, adding a potential domestic source. Scrap and spent catalysts vary in composition, so a process that works on one batch may need adjusting on the next, and defence buyers often run lengthy qualification. A repeat order tells you a customer was satisfied enough to buy again; treat it as validation, not proof of multi-year, multi-customer scale.

Tungsten supply diversification can follow several paths, including new mines such as Gentung-Browns Lake, recycled scrap and allied-country refining, and each carries a different cost and timeline.

What should investors in critical minerals take from this?

Scimplify is privately held, so direct public-market exposure is limited. The read-through runs instead through listed peers, policy-supported projects and strategic backers such as Hitachi and Henkel.

Where the risk sits

• Price and substitution: The 2025 tungsten spike could prompt substitution, inventory release and new supply.
• Policy dependence: DOE grants, tariffs, export controls and defence procurement can shift.
• Offtake: Repeat orders are weaker than take-or-pay contracts.
• Execution and feedstock: Scale-up can expose poor yields and inconsistent scrap inputs.
• Qualification: Defence and semiconductor testing can take months or years.
• Network control: Partner uptime and priority allocation are harder to guarantee.
• Dilution: Large projects often need repeated raises before revenue.
• Residual China dependence: Reagents or intermediates may still trace back to China.

Comparables show where evidence quality sits higher. MP Materials secured a $200 million Apple prepayment, Ucore plans a facility handling about 9,000 tonnes of feedstock a year, and Critical Materials Recycling won $3.4 million from the DOE for e-waste recovery.

CSIS, 25 March 2026 Permitting a mine is insufficient without a viable buyer and the scale to make processing economic.

Questions to ask next

1. Is there a disclosed, binding offtake with volume and term?
2. Does the company own or control the decisive processing plant?
3. Where do feedstock, reagents and intermediates originate?
4. Has the product passed customer qualification?
5. Are capacity, purity and yield figures published?
6. How much of the economics depends on policy support?

The raise signals where strategic capital is heading, but you should weigh it against disclosed offtake, owned capacity and verified origin before treating any processing story as de-risked.

For readers weighing the wider onshoring race, our full explainer on rare earth processing outside China shows which non-Chinese projects are actually reaching production.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Forward-looking statements are speculative and subject to change based on market developments and company performance.

What the raise settles, and what only disclosure can

The round matters because it targets the qualification and processing layer, not extraction. The strongest evidence so far is the investor base, the $7.5 million US allocation and the repeat tungsten order.

Commercial proof remains unreported. Volumes, purity data, plant ownership, feedstock origin, delivery schedules and binding long-term offtake are all still missing from the public record.

Over the next year, three disclosures would move the thesis from promising to proven: named US facilities, published production targets and customer offtake terms. Until then, the model is a credible bet rather than a demonstrated supply chain.